Literature DB >> 19484659

Procalcitonin values after dialysis is closely related to type of dialysis membrane.

Martina Montagnana1, Giuseppe Lippi, Nicola Tessitore, Gian Luca Salvagno, Elisa Danese, Giovanni Targher, Antonio Lupo, Gian Cesare Guidi.   

Abstract

BACKGROUND: Infections account for considerable morbidity and mortality in patients with chronic renal failure undergoing hemodialysis (HD). Diagnosis of infection in HD patients is challenging because the most used laboratory parameters may be increased even in the absence of infection. In this setting, procalcitonin (PCT) could be useful for detection of systemic bacterial infections.
METHODS: We measured high sensitivity C Reactive Protein (hsCRP) and PCT serum levels before and immediately after dialysis in 44 HD patients (22 treated with high- and 22 with low-flux membranes), without history of infections.
RESULTS: Patients on HD by high-flux membranes, but not by low-flux membranes, displayed mean PCT values significantly decreased after dialysis (high-flux: 0.50 vs. 0.26 ng/mL, p=0.005; low-flux: 0.41 vs. 0.42 ng/mL, p=0.863). HsCRP levels were unchanged. HsCRP correlated with PCT values both before and after HD only in patients on HD by low-flux membranes (r=0.51 and 0.47 before and after HD respectively; p<0.05).
CONCLUSIONS: Although PCT is considered a sensitive and specific diagnostic and prognostic marker of systemic bacterial infection, we suggest that specific reference ranges might be developed in patient with impaired renal function, also showing that and its clinical usefulness might be limited in patients undergoing HD with high-flux membranes.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19484659     DOI: 10.3109/00365510902993663

Source DB:  PubMed          Journal:  Scand J Clin Lab Invest        ISSN: 0036-5513            Impact factor:   1.713


  5 in total

1.  Microbial diagnostics in patients with presumed severe infection in the emergency department.

Authors:  S Hettwer; J Wilhelm; M Schürmann; H Ebelt; D Hammer; M Amoury; F Hofmann; A Oehme; D Wilhelms; A S Kekulé; T Klöss; K Werdan
Journal:  Med Klin Intensivmed Notfmed       Date:  2012-02       Impact factor: 0.840

2.  Procalcitonin in hemodialysis patients presenting with fever or chills to the emergency department.

Authors:  R Schneider; M J Cohen; S Benenson; O Duchin; Y S Haviv; M Elhalel-Darnitski; P D Levin
Journal:  Intern Emerg Med       Date:  2019-07-27       Impact factor: 3.397

3.  Use of procalcitonin in patients on chronic hemodialysis: procalcitonin is not related with increased serum calcitonin.

Authors:  Ken-Ichi Mori; Mitsuru Noguchi; Yasuhiro Sumino; Fuminori Sato; Hiromitsu Mimata
Journal:  ISRN Urol       Date:  2012-05-20

4.  Cutoff value of serum procalcitonin as a diagnostic biomarker of infection in end-stage renal disease patients.

Authors:  Wan Soo Lee; Dae Woong Kang; Jong Hun Back; Hyun Lee Kim; Jong Hoon Chung; Byung Chul Shin
Journal:  Korean J Intern Med       Date:  2015-02-27       Impact factor: 2.884

5.  Usefulness of serum procalcitonin as a diagnostic biomarker of infection in children with chronic kidney disease.

Authors:  Fatina I Fadel; Manal F Elshamaa; Eman A Elghoroury; Ahmed M Badr; Solaf Kamel; Marwa M El-Sonbaty; Mona Raafat; Hebatallh Farouk
Journal:  Arch Med Sci Atheroscler Dis       Date:  2016-05-05
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.